EUVIMEDEUVIMED entdecken
Vergleichsstudie

Beyond Oncologic Benefit: Diabetes Remission Following Long-Limb Roux-en-Y Reconstruction in Laparoscopic Gastric Cancer Surgery

Serdar Çulcu, Selim Tamam, Gökhan Gökten, Fırat Tekeş, Ezgi Altınsoy, İsmail Can Tercan, Ramazan Erdem Er, Aslı Bozer, Ali Ekrem Ünal, Salim Demirci

Journal of Laparoendoscopic & Advanced Surgical Techniques · 2025

DOI: 10.1177/10926429251389908 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Laparoendoscopic & Advanced Surgical Techniques, 2025. Verfasst von Serdar Çulcu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Oncology Department, Ankara University School of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastrectomy, Laparoscopy, Diabetes Mellitus, Type 2. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Few studies have compared conventional Roux-en-Y (RNY) reconstruction with oncometabolic surgical techniques for postoperative glycemic control in patients with gastric cancer and type 2 diabetes. This study evaluates the impact of long-limb (oncometabolic) RNY reconstruction on type 2 diabetes remission and glycemic control compared with the conventional method in patients undergoing laparoscopic radical gastrectomy. Materials and Methods: Between 2020 and 2024, 44 patients with gastric cancer and type 2 diabetes were enrolled at our institution. Of these, 19 patients underwent laparoscopic radical gastrectomy with oncometabolic RNY reconstruction, and 25 patients received conventional RNY reconstruction. Demographic data (age, gender, and BMI), preoperative glycemic parameters (fasting blood sugar and HbA1c), and tumor characteristics were recorded. Comparative analysis assessed diabetes treatment outcomes in the first postoperative year, including antidiabetic medication use, insulin requirements, and diabetes remission rates.

Results

Diabetes remission occurred in 52.6% of the oncometabolic surgery group compared with 20% in the conventional RNY group (P = .024). Multivariate logistic regression showed that oncometabolic surgery increased remission likelihood by 5.75 times (OR = 5.75; 95% CI: 1.17 to 28.21; P = .03). Antidiabetic medication use decreased by 78.9% in the oncometabolic group versus 24% in the conventional group (P = .001). Insulin requirements dropped from 36.8% to 5.3% in the oncometabolic group (P = .031).

Conclusions

Oncometabolic surgery provides significant advantages in gastric cancer patients not only from an oncological perspective but also from a metabolic perspective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsGastrectomyLaparoscopyDiabetes Mellitus, Type 2Anastomosis, Roux-en-YHumansMaleFemaleMiddle AgedAgedRetrospective StudiesRemission InductionHypoglycemic AgentsTreatment Outcome

Stichwörter der Autor:innen

Roux-en-Y reconstructiongastric cancerlaparoscopic gastrectomyoncometabolictype 2 diabetes

Substanzen

Hypoglycemic Agents

Autor:innen und Institutionen

  • Surgical Oncology Department, Ankara University School of Medicine, Ankara, Turkey.
  • Surgical Oncology Department, Ankara Training and Research Hospital, Ankara, Turkey.
  • Surgical Oncology Department, Mehmet Akif Ersoy State Hospital, Çanakkale, Turkey.
  • Gastroenterology Department, Ankara University School of Medicine, Ankara, Turkey.
  • Department of Statistics, Ankara University Faculty of Medicine, Ankara, Turkey.

Zitieren

APA

Çulcu, S., Tamam, S., Gökten, G., Tekeş, F., Altınsoy, E., Tercan, İ. C., Er, R. E., Bozer, A., Ünal, A. E., & Demirci, S. (2025). Beyond Oncologic Benefit: Diabetes Remission Following Long-Limb Roux-en-Y Reconstruction in Laparoscopic Gastric Cancer Surgery. Journal of Laparoendoscopic & Advanced Surgical Techniques. https://doi.org/10.1177/10926429251389908

Vancouver

Çulcu S, Tamam S, Gökten G, Tekeş F, Altınsoy E, Tercan İC, et al. Beyond Oncologic Benefit: Diabetes Remission Following Long-Limb Roux-en-Y Reconstruction in Laparoscopic Gastric Cancer Surgery. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2025. doi:10.1177/10926429251389908

BibTeX
@article{ulcu2025,
  author = {Çulcu, Serdar and Tamam, Selim and Gökten, Gökhan and Tekeş, Fırat and Altınsoy, Ezgi and Tercan, İsmail Can and Er, Ramazan Erdem and Bozer, Aslı and Ünal, Ali Ekrem and Demirci, Salim},
  title = {Beyond Oncologic Benefit: Diabetes Remission Following Long-Limb Roux-en-Y Reconstruction in Laparoscopic Gastric Cancer Surgery},
  journal = {Journal of Laparoendoscopic & Advanced Surgical Techniques},
  year = {2025},
  doi = {10.1177/10926429251389908}
}
Kostenlos starten →